324 related articles for article (PubMed ID: 9175839)
1. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
[TBL] [Abstract][Full Text] [Related]
2. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.
Hengel H; Koopmann JO; Flohr T; Muranyi W; Goulmy E; Hämmerling GJ; Koszinowski UH; Momburg F
Immunity; 1997 May; 6(5):623-32. PubMed ID: 9175840
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
[TBL] [Abstract][Full Text] [Related]
4. Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6.
Dugan GE; Hewitt EW
J Virol; 2008 Apr; 82(7):3271-82. PubMed ID: 18199642
[TBL] [Abstract][Full Text] [Related]
5. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.
Hewitt EW; Gupta SS; Lehner PJ
EMBO J; 2001 Feb; 20(3):387-96. PubMed ID: 11157746
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
Verweij MC; Ressing ME; Knetsch W; Quinten E; Halenius A; van Bel N; Hengel H; Drijfhout JW; van Hall T; Wiertz EJ
Mol Immunol; 2011 Mar; 48(6-7):835-45. PubMed ID: 21292324
[TBL] [Abstract][Full Text] [Related]
7. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
Pande NT; Powers C; Ahn K; Früh K
J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
[TBL] [Abstract][Full Text] [Related]
8. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6.
Kyritsis C; Gorbulev S; Hutschenreiter S; Pawlitschko K; Abele R; Tampé R
J Biol Chem; 2001 Dec; 276(51):48031-9. PubMed ID: 11606590
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.
Halenius A; Momburg F; Reinhard H; Bauer D; Lobigs M; Hengel H
J Biol Chem; 2006 Mar; 281(9):5383-90. PubMed ID: 16356928
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses.
Kim Y; Park B; Cho S; Shin J; Cho K; Jun Y; Ahn K
PLoS Pathog; 2008 Aug; 4(8):e1000123. PubMed ID: 18688275
[TBL] [Abstract][Full Text] [Related]
14. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
Chevalier MS; Daniels GM; Johnson DC
J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
[TBL] [Abstract][Full Text] [Related]
15. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses.
Momburg F; Hengel H
Curr Top Microbiol Immunol; 2002; 269():57-74. PubMed ID: 12224516
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
Chevalier MS; Johnson DC
J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
[TBL] [Abstract][Full Text] [Related]
17. Dependence of the localization and function of the human cytomegalovirus protein US6 on the transporter associated with antigen processing.
Dugan GE; Hewitt EW
J Gen Virol; 2009 Sep; 90(Pt 9):2234-8. PubMed ID: 19439551
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
19. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues.
Galocha B; Hill A; Barnett BC; Dolan A; Raimondi A; Cook RF; Brunner J; McGeoch DJ; Ploegh HL
J Exp Med; 1997 May; 185(9):1565-72. PubMed ID: 9151894
[TBL] [Abstract][Full Text] [Related]
20. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
